General Information of the Protein
Protein ID
PT01252
Protein Name
Serine/threonine-protein kinase PLK1
Secondarily
Protein Name
Polo-like kinase 1
Serine/threonine-protein kinase 13
Gene Name
PLK1
Secondarily
Gene Name
PLK
Sequence
MSAAVTAGKLARAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVLNKGLENPLPERPREKEEPVVRETGEVVDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSRSASNRLKAS
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Kinase
>
Protein Kinase
>
Other protein kinase group
>
Other protein kinase PLK family
Function
Serine/threonine-protein kinase that performs several important functions throughout M phase of the cell cycle, including the regulation of centrosome maturation and spindle assembly, the removal of cohesins from chromosome arms, the inactivation of anaphase-promoting complex/cyclosome (APC/C) inhibitors, and the regulation of mitotic exit and cytokinesis (PubMed:8991084, PubMed:11202906, PubMed:12207013, PubMed:12447691, PubMed:12524548, PubMed:12738781, PubMed:12852856, PubMed:12939256, PubMed:14532005, PubMed:14734534, PubMed:15070733, PubMed:15148369, PubMed:15469984, PubMed:16198290, PubMed:16247472, PubMed:16980960, PubMed:17081991, PubMed:17351640, PubMed:17376779, PubMed:17617734, PubMed:18174154, PubMed:18331714, PubMed:18418051, PubMed:18477460, PubMed:18521620, PubMed:18615013, PubMed:19160488, PubMed:19351716, PubMed:19468300, PubMed:19468302, PubMed:19473992, PubMed:19509060, PubMed:19597481, PubMed:23455478, PubMed:23509069). Polo-like kinase proteins act by binding and phosphorylating proteins that are already phosphorylated on a specific motif recognized by the POLO box domains (PubMed:8991084, PubMed:11202906, PubMed:12207013, PubMed:12447691, PubMed:12524548, PubMed:12738781, PubMed:12852856, PubMed:12939256, PubMed:14532005, PubMed:14734534, PubMed:15070733, PubMed:15148369, PubMed:15469984, PubMed:16198290, PubMed:16247472, PubMed:16980960, PubMed:17081991, PubMed:17351640, PubMed:17376779, PubMed:17617734, PubMed:18174154, PubMed:18331714, PubMed:18418051, PubMed:18477460, PubMed:18521620, PubMed:18615013, PubMed:19160488, PubMed:19351716, PubMed:19468300, PubMed:19468302, PubMed:19473992, PubMed:19509060, PubMed:19597481, PubMed:23455478, PubMed:23509069). Phosphorylates BORA, BUB1B/BUBR1, CCNB1, CDC25C, CEP55, ECT2, ERCC6L, FBXO5/EMI1, FOXM1, KIF20A/MKLP2, CENPU, NEDD1, NINL, NPM1, NUDC, PKMYT1/MYT1, KIZ, PPP1R12A/MYPT1, POLQ, PRC1, RACGAP1/CYK4, RAD51, RHNO1, SGO1, STAG2/SA2, TEX14, TOPORS, p73/TP73, TPT1, WEE1 and HNRNPU (PubMed:8991084, PubMed:11202906, PubMed:12207013, PubMed:12447691, PubMed:12524548, PubMed:12738781, PubMed:12852856, PubMed:12939256, PubMed:14532005, PubMed:14734534, PubMed:15070733, PubMed:15148369, PubMed:15469984, PubMed:16198290, PubMed:16247472, PubMed:16980960, PubMed:17081991, PubMed:17218258, PubMed:17351640, PubMed:17376779, PubMed:17617734, PubMed:18174154, PubMed:18331714, PubMed:18418051, PubMed:18477460, PubMed:18521620, PubMed:18615013, PubMed:19160488, PubMed:19351716, PubMed:19468300, PubMed:19468302, PubMed:19473992, PubMed:19509060, PubMed:22325354, PubMed:19597481, PubMed:23455478, PubMed:23509069, PubMed:25986610, PubMed:26811421, PubMed:37674080, PubMed:37440612). Plays a key role in centrosome functions and the assembly of bipolar spindles by phosphorylating KIZ, NEDD1 and NINL (PubMed:16980960, PubMed:19509060). NEDD1 phosphorylation promotes subsequent targeting of the gamma-tubulin ring complex (gTuRC) to the centrosome, an important step for spindle formation (PubMed:19509060). Phosphorylation of NINL component of the centrosome leads to NINL dissociation from other centrosomal proteins (PubMed:12852856). Involved in mitosis exit and cytokinesis by phosphorylating CEP55, ECT2, KIF20A/MKLP2, CENPU, PRC1 and RACGAP1 (PubMed:12939256, PubMed:16247472, PubMed:17351640, PubMed:19468300, PubMed:19468302). Recruited at the central spindle by phosphorylating and docking PRC1 and KIF20A/MKLP2; creates its own docking sites on PRC1 and KIF20A/MKLP2 by mediating phosphorylation of sites subsequently recognized by the POLO box domains (PubMed:12939256, PubMed:17351640). Phosphorylates RACGAP1, thereby creating a docking site for the Rho GTP exchange factor ECT2 that is essential for the cleavage furrow formation (PubMed:19468300, PubMed:19468302). Promotes the central spindle recruitment of ECT2 (PubMed:16247472). Plays a central role in G2/M transition of mitotic cell cycle by phosphorylating CCNB1, CDC25C, FOXM1, CENPU, PKMYT1/MYT1, PPP1R12A/MYPT1 and WEE1 (PubMed:11202906, PubMed:12447691, PubMed:12524548, PubMed:19160488). Part of a regulatory circuit that promotes the activation of CDK1 by phosphorylating the positive regulator CDC25C and inhibiting the negative regulators WEE1 and PKMYT1/MYT1 (PubMed:11202906). Also acts by mediating phosphorylation of cyclin-B1 (CCNB1) on centrosomes in prophase (PubMed:12447691, PubMed:12524548). Phosphorylates FOXM1, a key mitotic transcription regulator, leading to enhance FOXM1 transcriptional activity (PubMed:19160488). Involved in kinetochore functions and sister chromatid cohesion by phosphorylating BUB1B/BUBR1, FBXO5/EMI1 and STAG2/SA2 (PubMed:15469984, PubMed:15148369, PubMed:17376779, PubMed:18331714). PLK1 is high on non-attached kinetochores suggesting a role of PLK1 in kinetochore attachment or in spindle assembly checkpoint (SAC) regulation (PubMed:17617734). Required for kinetochore localization of BUB1B (PubMed:17376779). Regulates the dissociation of cohesin from chromosomes by phosphorylating cohesin subunits such as STAG2/SA2 (By similarity). Phosphorylates SGO1: required for spindle pole localization of isoform 3 of SGO1 and plays a role in regulating its centriole cohesion function (PubMed:18331714). Mediates phosphorylation of FBXO5/EMI1, a negative regulator of the APC/C complex during prophase, leading to FBXO5/EMI1 ubiquitination and degradation by the proteasome (PubMed:15469984, PubMed:15148369). Acts as a negative regulator of p53 family members: phosphorylates TOPORS, leading to inhibit the sumoylation of p53/TP53 and simultaneously enhance the ubiquitination and subsequent degradation of p53/TP53 (PubMed:19473992). Phosphorylates the transactivation domain of the transcription factor p73/TP73, leading to inhibit p73/TP73-mediated transcriptional activation and pro-apoptotic functions. Phosphorylates BORA, and thereby promotes the degradation of BORA (PubMed:18521620). Contributes to the regulation of AURKA function (PubMed:18662541, PubMed:18615013). Also required for recovery after DNA damage checkpoint and entry into mitosis (PubMed:18662541, PubMed:18615013). Phosphorylates MISP, leading to stabilization of cortical and astral microtubule attachments required for proper spindle positioning (PubMed:23509069). Together with MEIKIN, acts as a regulator of kinetochore function during meiosis I: required both for mono-orientation of kinetochores on sister chromosomes and protection of centromeric cohesin from separase-mediated cleavage (By similarity). Phosphorylates CEP68 and is required for its degradation (PubMed:25503564). Regulates nuclear envelope breakdown during prophase by phosphorylating DCTN1 resulting in its localization in the nuclear envelope (PubMed:20679239). Phosphorylates the heat shock transcription factor HSF1, promoting HSF1 nuclear translocation upon heat shock (PubMed:15661742). Phosphorylates HSF1 also in the early mitotic period; this phosphorylation regulates HSF1 localization to the spindle pole, the recruitment of the SCF(BTRC) ubiquitin ligase complex induicing HSF1 degradation, and hence mitotic progression (PubMed:18794143). Regulates mitotic progression by phosphorylating RIOK2 (PubMed:21880710). Through the phosphorylation of DZIP1 regulates the localization during mitosis of the BBSome, a ciliary protein complex involved in cilium biogenesis (PubMed:27979967). Regulates DNA repair during mitosis by mediating phosphorylation of POLQ and RHNO1, thereby promoting POLQ recruitment to DNA damage sites (PubMed:37674080, PubMed:37440612).
    Show/Hide
Uniprot ID
Primary ID:
P53350

Secondarily ID:
Q15153
Q99746
    Show/Hide
Ensembl ID
ENSG00000166851
HGNC ID
HGNC:9077
Subcellular Location
Nucleus
Chromosome
Centromere
Kinetochore
Cytoplasm
Cytoskeleton
Microtubule organizing center
Centrosome
Cytoplasm
Cytoskeleton
Spindle
Midbody
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000023 , BTI-Tn-5B1-4
Compound ID Compound Name Compound Formula
CP0017650
8-(Phenylamino)-1-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C18H15F3N6O
 1
1
IC50 = 6 nM
   TI
   LI
   LO
   TS
CP0639837
8-[2-methoxy-5-(4-methylpiperazin-1-yl)anilino]-1-methyl-4,5-dihydropyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C23H28N8O2
 1
1
IC50 = 7 nM
   TI
   LI
   LO
   TS
CP0018881
1-Methyl-8-[(2-methylphenyl)amino]-4,5-dihydro-1H-pyrazolo-[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C18H18N6O
 1
1
IC50 = 15 nM
   TI
   LI
   LO
   TS
CP0026702
8-{[2-Methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}-1-methyl-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C23H28N8O2
 1
1
IC50 = 40 nM
   TI
   LI
   LO
   TS
CP0018224
8-[(2-Methoxyphenyl)amino]-1-methyl-4,5-dihydro-1H-pyrazolo-[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C18H18N6O2
 1
1
IC50 = 42 nM
   TI
   LI
   LO
   TS
CP0018223
1-Methyl-8-{[3-(trifluoromethyl)phenyl]amino}-4,5-dihydro-1Hpyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C18H15F3N6O
 1
1
IC50 = 51 nM
   TI
   LI
   LO
   TS
CP0017007
pyrazolo[4,3-h]quinazoline-3-carboxamide, 1
   Show/Hide
C17H16N6O
 1
1
IC50 = 68 nM
   TI
   LI
   LO
   TS
CP0020461
1-Methyl-8-{[2-(methylsulfanyl)phenyl]amino}-4,5-dihydro-1Hpyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C18H18N6OS
 1
1
IC50 = 97 nM
   TI
   LI
   LO
   TS
CP0026700
8-[(3-Acetylphenyl)amino]-1-methyl-4,5-dihydro-1H-pyrazolo-[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C19H18N6O2
 1
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
CP0017708
8-{[2-Acetyl-5-(4-methylpiperazin-1-yl)phenyl]amino}-1-methyl-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C24H28N8O2
 1
1
IC50 = 109 nM
   TI
   LI
   LO
   TS
CP0015510
1-Methyl-8-{[2-(methylamino)phenyl]amino}-4,5-dihydro-1Hpyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C18H19N7O
 1
1
IC50 = 110 nM
   TI
   LI
   LO
   TS
CP0025690
1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid
   Show/Hide
C17H15N5O2
 1
1
IC50 = 110 nM
   TI
   LI
   LO
   TS
CP0029110
8-[(2-Fluorophenyl)amino]-1-methyl-4,5-dihydro-1H-pyrazolo-[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C17H15FN6O
 1
1
IC50 = 125 nM
   TI
   LI
   LO
   TS
CP0018222
8-[(3-Methoxyphenyl)amino]-1-methyl-4,5-dihydro-1H-pyrazolo-[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C18H18N6O2
 1
1
IC50 = 135 nM
   TI
   LI
   LO
   TS
CP0016541
1-Cyclohexyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]-quinazoline-3-carboxamide
   Show/Hide
C22H24N6O
 1
1
IC50 = 143 nM
   TI
   LI
   LO
   TS
CP0027872
8-[(2-Aminophenyl)amino]-1-methyl-4,5-dihydro-1H-pyrazolo-[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C17H17N7O
 1
1
IC50 = 150 nM
   TI
   LI
   LO
   TS
CP0019922
8-[(4-Acetylphenyl)amino]-1-methyl-4,5-dihydro-1H-pyrazolo-[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C19H18N6O2
 1
1
IC50 = 197 nM
   TI
   LI
   LO
   TS
CP0025241
8-(Phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C16H14N6O
 1
1
IC50 = 248 nM
   TI
   LI
   LO
   TS
CP0028619
8-[(4-Methoxyphenyl)amino]-1-methyl-4,5-dihydro-1H-pyrazolo-[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C18H18N6O2
 1
1
IC50 = 256 nM
   TI
   LI
   LO
   TS
CP0017472
1-Methyl-8-[(2-phenoxyphenyl)amino]-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C23H20N6O2
 1
1
IC50 = 278 nM
   TI
   LI
   LO
   TS
CP0025689
8-[(2-Acetylphenyl)amino]-1-methyl-4,5-dihydro-1H-pyrazolo-[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C19H18N6O2
 1
1
IC50 = 346 nM
   TI
   LI
   LO
   TS
CP0025912
1-Methyl-8-{[2-(propan-2-yl)phenyl]amino}-4,5-dihydro-1Hpyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C20H22N6O
 1
1
IC50 = 365 nM
   TI
   LI
   LO
   TS
CP0025243
8-(Phenylamino)-1-(propan-2-yl)-4,5-dihydro-1H-pyrazolo[4,3-h]-quinazoline-3-carboxamide
   Show/Hide
C19H20N6O
 1
1
IC50 = 430 nM
   TI
   LI
   LO
   TS
CP0017652
1-Methyl-8-{[2-(trifluoromethyl)phenyl]amino}-4,5-dihydro-1Hpyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C18H15F3N6O
 1
1
IC50 = 432 nM
   TI
   LI
   LO
   TS
CP0027123
8-{[2-Acetyl-4-(4-methylpiperazin-1-yl)phenyl]amino}-1-methyl-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C24H28N8O2
 1
1
IC50 = 464 nM
   TI
   LI
   LO
   TS
CP0017651
1-Methyl-8-[(2-nitrophenyl)amino]-4,5-dihydro-1H-pyrazolo-[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C17H15N7O3
 1
1
IC50 = 488 nM
   TI
   LI
   LO
   TS
CP0025242
1-Methyl-8-{[4-(trifluoromethyl)phenyl]amino}-4,5-dihydro-1Hpyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C18H15F3N6O
 1
1
IC50 = 872 nM
   TI
   LI
   LO
   TS
CP0018233
8-[(2-Benzylphenyl)amino]-1-methyl-4,5-dihydro-1H-pyrazolo-[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C24H22N6O
 1
1
IC50 = 943 nM
   TI
   LI
   LO
   TS
CP0018232
1-Methyl-8-{[2-(phenylamino)phenyl]amino}-4,5-dihydro-1Hpyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C23H21N7O
 1
1
IC50 = 949 nM
   TI
   LI
   LO
   TS
CP0026742
methyl 2-[(3-carbamoyl-1-methyl-4,5-dihydropyrazolo[4,3-h]quinazolin-8-yl)amino]benzoate
   Show/Hide
C19H18N6O3
 1
1
IC50 = 1117 nM
   TI
   LI
   LO
   TS
CP0027122
8-(Biphenyl-2-ylamino)-1-methyl-4,5-dihydro-1H-pyrazolo[4,3-h]-quinazoline-3-carboxamide
   Show/Hide
C23H20N6O
 1
1
IC50 = 1565 nM
   TI
   LI
   LO
   TS
CP0023011
1-Methyl-8-{[2-(phenylcarbonyl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C24H20N6O2
 1
1
IC50 = 1969 nM
   TI
   LI
   LO
   TS
CP0025688
1-Methyl-8-{[2-(phenylsulfanyl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C23H20N6OS
 1
1
IC50 = 2033 nM
   TI
   LI
   LO
   TS
CP0017471
8-{[2-Acetyl-3-(4-methylpiperazin-1-yl)phenyl]amino}-1-methyl-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C24H28N8O2
 1
1
IC50 = 2051 nM
   TI
   LI
   LO
   TS
CP0023674
8-[(2-Carbamoylphenyl)amino]-1-methyl-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C18H17N7O2
 1
1
IC50 = 2076 nM
   TI
   LI
   LO
   TS
CP0018580
8-{[2-(Acetylamino)phenyl]amino}-1-methyl-4,5-dihydro-1Hpyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C19H19N7O2
 1
1
IC50 = 2523 nM
   TI
   LI
   LO
   TS
CP0026741
1-Methyl-8-[(2-sulfamoylphenyl)amino]-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C17H17N7O3S
 1
1
IC50 = 3733 nM
   TI
   LI
   LO
   TS
CP0016827
pyrazolo[4,3-h]quinazoline-3-carboxamide, 16
   Show/Hide
C18H18N6O
 1
1
IC50 = 4215 nM
   TI
   LI
   LO
   TS
CP0015588
1-Methyl-8-[(4-nitrophenyl)amino]-4,5-dihydro-1H-pyrazolo-[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C17H15N7O3
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0016540
1-Methyl-8-[(3-nitrophenyl)amino]-4,5-dihydro-1H-pyrazolo-[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C17H15N7O3
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0018215
pyrazolo[4,3-h]quinazoline-3-carboxamide, 20
   Show/Hide
C23H20N6O
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0018880
1-(1-Methylpiperidin-4-yl)-8-(phenylamino)-4,5-dihydro-1Hpyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C22H25N7O
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0022208
8-(Phenylamino)-1-[2-(piperidin-1-yl)ethyl]-4,5-dihydro-1Hpyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C23H27N7O
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0023532
ethyl 8-anilino-1-methyl-4,5-dihydropyrazolo[4,3-h]quinazoline-3-carboxylate
   Show/Hide
C19H19N5O2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0023794
pyrazolo[4,3-h]quinazoline-3-carboxamide, 17
   Show/Hide
C20H20N6O
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0025238
pyrazolo[4,3-h]quinazoline-3-carboxamide, 19
   Show/Hide
C22H24N6O
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0026701
1-Phenyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]-quinazoline-3-carboxamide
   Show/Hide
C22H18N6O
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0044060
4-{[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl]amino}-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide
   Show/Hide
C28H39N7O3
 9
1 IC50 = 0.083 nM
2 IC50 = 0.8 nM
3 IC50 = 0.83 nM
4 IC50 < 2.6 nM
5 IC50 = 4 nM
6 IC50 = 8 nM
7 IC50 = 106 nM
8 Kd = 0.19 nM
9 Ki = 3 nM
CP0338318
[(2R,3S)-3-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-acetylpyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]amino]-3-[3-(8-phenyloctyl)imidazol-4-yl]propanoyl]amino]-3-hydroxypropanoyl]amino]-4-amino-4-oxobutan-2-yl] dihydrogen phosphate
   Show/Hide
C40H63N8O11P
 2
1 IC50 = 4 nM
2 IC50 = 150 nM
CP0254459
(R)-3-(1-(2-chloro-4-(hydroxymethyl)phenyl)ethoxy)-5-(imidazo[1,2-a]pyridin-3-yl)thiophene-2-carboxamide
   Show/Hide
C21H18ClN3O3S
 1
1 IC50 = 4.9 nM
CP0322418
(R)-3-(1-(2-chlorophenyl)ethoxy)-5-(imidazo[1,2-a]pyridin-3-yl)thiophene-2-carboxamide
   Show/Hide
C20H16ClN3O2S
 1
1 IC50 = 7 nM
CP0254460
(R)-3-(1-(2-chlorophenyl)ethoxy)-5-(6-(hydroxymethyl)imidazo[1,2-a]pyridin-3-yl)thiophene-2-carboxamide
   Show/Hide
C21H18ClN3O3S
 1
1 IC50 = 7.3 nM
CP0019419
(R)-3-(1-(4-((tert-butylamino)methyl)-2-(difluoromethoxy)phenyl)ethoxy)-5-(imidazo[1,2-a]pyridin-3-yl)thiophene-2-carboxamide
   Show/Hide
C26H28F2N4O3S
 1
1 IC50 = 9.8 nM
CP0639837
8-[2-methoxy-5-(4-methylpiperazin-1-yl)anilino]-1-methyl-4,5-dihydropyrazolo[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C23H28N8O2
 1
1 IC50 = 10 nM
CP0018881
1-Methyl-8-[(2-methylphenyl)amino]-4,5-dihydro-1H-pyrazolo-[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C18H18N6O
 2
1 IC50 = 14 nM
2 IC50 = 15 nM
CP0362850
(R)-3-(1-(2-chloro-4-((methylamino)methyl)phenyl)ethoxy)-5-(imidazo[1,2-a]pyridin-3-yl)thiophene-2-carboxamide
   Show/Hide
C22H21ClN4O2S
 1
1 IC50 = 16 nM
CP0297360
(R)-3-(1-(4-((tert-butylamino)methyl)-2-(difluoromethyl)phenyl)ethoxy)-5-(imidazo[1,2-a]pyridin-3-yl)thiophene-2-carboxamide
   Show/Hide
C26H28F2N4O2S
 1
1 IC50 = 20 nM
CP0191857
(R)-3-(1-(4-((tert-butylamino)methyl)-2-chlorophenyl)ethoxy)-5-(imidazo[1,2-a]pyridin-3-yl)thiophene-2-carboxamide
   Show/Hide
C25H27ClN4O2S
 1
1 IC50 = 21 nM
CP0305796
(R)-3-(1-(2-chloro-4-((ethylamino)methyl)phenyl)ethoxy)-5-(imidazo[1,2-a]pyridin-3-yl)thiophene-2-carboxamide
   Show/Hide
C23H23ClN4O2S
 1
1 IC50 = 21 nM
CP0254458
5-(imidazo[1,2-a]pyridin-3-yl)-3-(2-(trifluoromethyl)benzyloxy)thiophene-2-carboxamide
   Show/Hide
C20H14F3N3O2S
 1
1 IC50 = 22 nM
CP0275366
(R)-3-(1-(2-chloro-4-((dimethylamino)methyl)phenyl)ethoxy)-5-(imidazo[1,2-a]pyridin-3-yl)thiophene-2-carboxamide
   Show/Hide
C23H23ClN4O2S
 1
1 IC50 = 22 nM
CP0230940
(R)-3-(1-(2-chloro-4-((isopropylamino)methyl)phenyl)ethoxy)-5-(imidazo[1,2-a]pyridin-3-yl)thiophene-2-carboxamide
   Show/Hide
C24H25ClN4O2S
 1
1 IC50 = 28 nM
CP0148394
4-[[(7S)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide
   Show/Hide
C28H39N7O3
 1
1 IC50 = 32.5 nM
CP0191856
3-(2-chlorobenzyloxy)-5-(imidazo[1,2-a]pyridin-3-yl)thiophene-2-carboxamide
   Show/Hide
C19H14ClN3O2S
 1
1 IC50 = 35 nM
CP0305795
5-(1H-1,3-benzodiazol-1-yl)-3-{[2-(trifluoromethyl)phenyl]methoxy}thiophene-2-carboxamide
   Show/Hide
C20H14F3N3O2S
 1
1 IC50 = 35 nM
CP0362849
3-(1-(2-chloro-5-(hydroxymethyl)phenyl)ethoxy)-5-(imidazo[1,2-a]pyridin-3-yl)thiophene-2-carboxamide
   Show/Hide
C21H18ClN3O3S
 1
1 IC50 = 39 nM
CP0018224
8-[(2-Methoxyphenyl)amino]-1-methyl-4,5-dihydro-1H-pyrazolo-[4,3-h]quinazoline-3-carboxamide
   Show/Hide
C18H18N6O2
 1
1 IC50 = 42 nM
CP0017007
pyrazolo[4,3-h]quinazoline-3-carboxamide, 1
   Show/Hide
C17H16N6O
 1
1 IC50 = 68 nM
CP0294030
(R)-3-(1-(2-(hydroxymethyl)phenyl)ethoxy)-5-(imidazo[1,2-a]pyridin-3-yl)thiophene-2-carboxamide
   Show/Hide
C21H19N3O3S
 1
1 IC50 = 88 nM
CP0117325
[(2R,3S)-3-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-acetylpyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-amino-4-oxobutan-2-yl] dihydrogen phosphate
   Show/Hide
C26H43N8O11P
 1
1 IC50 = 620 nM
CP0571784
7-fluoro-1-sulfanylidene-4-(3,3,3-trifluoropropyl)-2H-[1,2,4]triazolo[4,3-a]quinazolin-5-one
   Show/Hide
C12H8F4N4OS
 1
1 IC50 = 750 nM
CP0533127
4-(cyclopropylmethyl)-7-fluoro-1-sulfanylidene-2H-[1,2,4]triazolo[4,3-a]quinazolin-5-one
   Show/Hide
C13H11FN4OS
 1
1 IC50 = 770 nM
CP0552946
7-fluoro-4-(2-pyridin-2-ylethyl)-1-sulfanylidene-2H-[1,2,4]triazolo[4,3-a]quinazolin-5-one
   Show/Hide
C16H12FN5OS
 1
1 IC50 = 870 nM
CP0471553
7-fluoro-4-(2-pyridin-4-ylethyl)-1-sulfanylidene-2H-[1,2,4]triazolo[4,3-a]quinazolin-5-one
   Show/Hide
C16H12FN5OS
 1
1 IC50 = 890 nM
CP0565031
N-[3-(7-fluoro-5-oxo-1-sulfanylidene-2H-[1,2,4]triazolo[4,3-a]quinazolin-4-yl)propyl]-2-(3-methoxyphenyl)acetamide
   Show/Hide
C21H20FN5O3S
 1
1 IC50 = 960 nM
CP0573023
2-(4-cyanophenyl)-N-[3-(7-fluoro-5-oxo-1-sulfanylidene-2H-[1,2,4]triazolo[4,3-a]quinazolin-4-yl)propyl]acetamide
   Show/Hide
C21H17FN6O2S
 1
1 IC50 = 990 nM
CP0016827
pyrazolo[4,3-h]quinazoline-3-carboxamide, 16
   Show/Hide
C18H18N6O
 1
1 IC50 = 4215 nM
CP0528681
5-methyl-2-[(4-octylsulfanylbenzoyl)amino]benzoic acid
   Show/Hide
C23H29NO3S
 1
1 IC50 = 26800 nM
CP0018215
pyrazolo[4,3-h]quinazoline-3-carboxamide, 20
   Show/Hide
C23H20N6O
 1
1 IC50 > 10000 nM
CP0041537
5-[6-[(4-methylpiperazin-1-yl)methyl]benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide
   Show/Hide
C27H28F3N5O2S
 3
1 Kd = 0.094 nM
2 Ki < 0.5 nM
3 Ki = 2.2 nM
CP0217497
3-(tert-butylamino)-4-[[2-(9H-fluoren-2-ylamino)pyrimidin-4-yl]amino]cyclobut-3-ene-1,2-dione
   Show/Hide
C25H23N5O2
 1
1 Ki = 4 nM
CP0054396
3-(tert-butylamino)-4-[[2-(4-pyridin-4-ylanilino)pyrimidin-4-yl]amino]cyclobut-3-ene-1,2-dione
   Show/Hide
C23H22N6O2
 1
1 Ki = 5 nM
CP0388384
3-(tert-butylamino)-4-[[2-[4-(1H-pyrazol-4-yl)anilino]pyrimidin-4-yl]amino]cyclobut-3-ene-1,2-dione
   Show/Hide
C21H21N7O2
 1
1 Ki = 10 nM
CP0391978
3-(tert-butylamino)-4-[[2-(9H-carbazol-2-ylamino)pyrimidin-4-yl]amino]cyclobut-3-ene-1,2-dione
   Show/Hide
C24H22N6O2
 1
1 Ki = 10 nM
CP0274254
3-(tert-butylamino)-4-[[2-(4-phenylanilino)pyrimidin-4-yl]amino]cyclobut-3-ene-1,2-dione
   Show/Hide
C24H23N5O2
 1
1 Ki = 14 nM
CP0282699
3-(tert-butylamino)-4-[[2-[4-(thiadiazol-4-yl)anilino]pyrimidin-4-yl]amino]cyclobut-3-ene-1,2-dione
   Show/Hide
C20H19N7O2S
 1
1 Ki = 15 nM
CP0077493
3-(tert-butylamino)-4-[[2-(1H-indazol-5-ylamino)pyrimidin-4-yl]amino]cyclobut-3-ene-1,2-dione
   Show/Hide
C19H19N7O2
 1
1 Ki = 17 nM
CP0071268
3-[[2-[(1-acetyl-2,3-dihydroindol-5-yl)amino]pyrimidin-4-yl]amino]-4-(tert-butylamino)cyclobut-3-ene-1,2-dione
   Show/Hide
C22H24N6O3
 1
1 Ki = 20 nM
CP0566811
3-(tert-butylamino)-4-[[2-(2,3-dihydro-1-benzofuran-5-ylamino)pyrimidin-4-yl]amino]cyclobut-3-ene-1,2-dione
   Show/Hide
C20H21N5O3
 1
1 Ki = 22 nM
CP0282697
3-(tert-butylamino)-4-[[2-(4-pyridin-3-ylanilino)pyrimidin-4-yl]amino]cyclobut-3-ene-1,2-dione
   Show/Hide
C23H22N6O2
 1
1 Ki = 28 nM
CP0335238
3-[[2-(1,3-benzothiazol-6-ylamino)pyrimidin-4-yl]amino]-4-(tert-butylamino)cyclobut-3-ene-1,2-dione
   Show/Hide
C19H18N6O2S
 1
1 Ki = 43 nM
CP0430291
3-(tert-butylamino)-4-[[2-(4-pyridin-2-ylanilino)pyrimidin-4-yl]amino]cyclobut-3-ene-1,2-dione
   Show/Hide
C23H22N6O2
 1
1 Ki = 82 nM
CP0331679
3-(tert-butylamino)-4-[[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]amino]cyclobut-3-ene-1,2-dione
   Show/Hide
C22H26N6O3
 1
1 Ki = 175 nM
Clinical Information about the Protein
Target 1 ( Polo-like kinase 1 (PLK1) )
Target Type Clinical trial Target
Disease 6 Target-related Diseases  6
1 Solid tumour/cancer [ICD-11: 2A00-2F9Z]
2 Acute myeloid leukaemia [ICD-11: 2A60]
3 Non-hodgkin lymphoma [ICD-11: 2B33.5]
4 Prostate cancer [ICD-11: 2C82.0]
5 Lymphoma [ICD-11: 2A80-2A86]
6 Nasopharyngeal carcinoma [ICD-11: 2B6B]
Clinical Trial Drug(s) 5 Clinical Trial Drugs  5
1 Rigosertib Phase 3
Solid tumour/cancer
2 BI 2536 Phase 2
Acute myeloid leukaemia
3 PCM-075 Phase 2
Acute myeloid leukaemia
4 GSK461364 Phase 1
Non-hodgkin lymphoma
5 TAK-960 Phase 1
Solid tumour/cancer
Discontinued Drug(s) 1 Discontinued Drug  1
1 HMN-214 Discontinued in Phase 1
Prostate cancer
Investigative Drug(s) 2 Investigative Drugs  2
1 MLN-0905 Investigative
Lymphoma
2 Ro5203280 Investigative
Nasopharyngeal carcinoma
Preclinical Drug(s) 1 Preclinical Drug  1
1 DAP-81 Preclinical
Solid tumour/cancer
Target 2 ( PLK1 messenger RNA (PLK1 mRNA) )
Target Type Clinical trial Target